UBS Adjusts Estimates and PT on Colfax Corporation (CFX); Multi-Year Growth Story Seems on Track

August 2, 2012 2:03 PM EDT Send to a Friend
UBS maintains a 'Buy' on Colfax Corporation (NYSE: CFX) price target of $38.00 (from $40.00).

Analyst, Jason Feldman, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login